14 research outputs found

    CKD and cardiac damage.

    No full text
    <p>Panel A. Difference in left ventricular mass/h<sup>2.7</sup> between patients with CKD and the rest of the population. Panel B. Prevalence of ventricular hypertrophy in patients with CKD vs the rest of the population.</p

    Daytime PP associated with LVM/h<sup>2.7</sup> in a linear regression model.

    No full text
    <p>BMI and age were also two other important independent factors for LVM/h<sup>2.7</sup>.</p>*<p>TIS = Treatment Intensity Score.</p

    Night-time PP associated with LVM/h<sup>2.7</sup> in a linear regression model.

    No full text
    <p>BMI and age were also two other important independent factors for LVM/h<sup>2.7</sup>.</p>*<p>TIS = Treatment Intensity Score.</p

    Night-time SBP associated with LVM/h<sup>2.7</sup> in a linear regression model.

    No full text
    <p>BMI and age were also two other important independent factors for LVM/h<sup>2.7</sup>.</p>*<p>TIS = Treatment Intensity Score.</p

    Correlation between ABPM values and CKD stages.

    No full text
    <p>Panel A. Difference in night-time BP between CKD stages. Panel B. Difference in 24 h PP between CKD stages. Panel C. Difference in daytime PP between CKD stages. Panel D. Difference in night-time PP between CKD stages.</p

    Independent risk factors for LVH/h<sup>2.7</sup> assessed by logistic regression models.

    No full text
    <p>Model 1 included waist, SBP, DBP, fasting glucose, HDL cholesterol and triglycerides along with diagnosis of diabetes or dyslipidemia as covariates. Model 2 included all model 1 variables except waist, which was substituted by BMI, as covariates. No adjustment for sex was applied because of the different partition values for LVH/h<sup>2.7</sup> used for males and females.</p
    corecore